The effect of hydrotraining on adults with Inclusion Body Myositis: Quality of Life and muscle endurance

[1] H. Alexanderson, “Exercise in myositis”, Current Treatment Options in Rheumatol

ogy,4(4),289-298.,2018.

[2] T.M.Association,“Skincareformyositis”,https://www.myositis.org,2015.

[3] A. N. Jørgensen, P. Aagaard, U. Frandsen, E. Boyle, and L. P. Diederichsen, “Blood

flow restricted resistance training in patients with sporadic inclusion body myositis:

A randomized controlled trial”, Scandinavian Journal of Rheumatology, 47(5), 400

409,2018.

[4] A. Wallace, A. Pietrusz, E. Dewar, M. Dudziec, K. Jones, P. Hennis, A. Sterr, G. Baio,

P. M. Machado, M. Laurá, I. Skorupinska, M. Skorupinska, K. Butcher, M. Trenell,

M.M.Reilly,M.G.Hanna,andG.M.Ramdharry,“Communityexerciseisfeasiblefor

neuromusculardiseasesandcanimproveaerobiccapacity.”,Neurology,Apr.2019.

[5] H. Alexanderson, “Physical exercise as a treatment for adult and juvenile myositis,

280(1),75-96.”,JournalofInternalMedicine,2016.

[6] G. F. Wiesinger, M. Quittan, M. Aringer, A. Seeber, B. Volc-Platzer, J. Smolen, and W.

Graninger,“Improvementofphysicalfitnessandmusclestrengthinpolymyositis

/dermatomyositispatientsbyatrainingprogramme,37(2),196-200.”,BritishJournal

ofRheumatology,1998.

[7] H. Alexanderson, C. Stenström, G. Jenner, and I. Lundberg, “The safety of a resistive

homeexerciseprograminpatientswithrecentonsetactivepolymyositisordermato

myositis,29(5),295-301.”,ScandinavianJournalofRheumatology,2000.

[8] V. Tiffreau, F. Rannou, F. Kopciuch, E. Hachulla, L. Mouthon, P. Thoumie, J. Sibilia, E.

Drumez, and A. Thevenon, “Postrehabilitation functional improvements in patients

with inflammatory myopathies: The results of a randomized controlled trial, 98(2),

227-234.”,ArchivesofPhysicalMedicineandRehabilitation,2017

[9] I. E. Lundberg, A. Tjärnlund, M. Bottai, V. P. Werth, C. Pilkington, M. de Visser, L. Al

fredsson,A.A.Amato,R.J.Barohn,M.H.Liang,J.A.Singh,R.Aggarwal,S.Arnardot

tir, H. Chinoy, R. G. Cooper, K. Danko, M. M. Dimachkie, B. M. Feldman, I. G.-D. L.

Torre, P. Gordon, T. Hayashi, J. D. Katz, H. Kohsaka, P. A. Lachenbruch, B. A. Lang,

Y. Li, C. V. Oddis, M. Olesinska, A. M. Reed, L. Rutkowska-Sak, H. Sanner, A. Selva

O’Callaghan, Y. W. Song, J. Vencovsky, S. R. Ytterberg, F. W. Miller, and L. G. Rider,

“International myositis classification criteria project consortium, the euromyositis

register,69(12),2271-2282.”,ArtritisRheumatology,2017.

[10] R.C.Griggs,V.Askanas,S.DiMauro,A.Engel,G.Katpati,J.R.Mendell,andL.P.Row

land, “Inclusion body myositis and myopathies, 38(5), 705-713.”, Annals of Neurol

ogy,1995.

[11] C. Lindberg and A. Oldfors, “Prognosis and prognostic factors in sporadic inclusion

bodymyositis,125(5),353-358.”,ActaNeurologicaScandinavica,2012.

[12] M. R. Rose, M. P. McDermott, C. A. Thornton, C. Palenski, W. B. Martens, and R. C.

Griggs,“Aprospectivenaturalhistorystudyofinclusionbodymyositis:Implications

forclinicaltrials”,Neurology,2001.

[13] H. Alexanderson, “Exercise in inflammatory myopathies, including inclusion body

myositis,14(3),244-251.”,CurrentRheumatologyReports,2012.

[14] M.C.Dalakas,G.Rakocevic,J.Schmidt,M.Salajegheh,B.McElroy,M.O.Harris–Love,

J. A. Shrader, E. W. Levy, J. Dambrosia, R. L. Kampen, D. A. Bruno, and 1.-1. Allan

D. Kirk 132(Pt6), “Effect of alemtuzumab (campath 1-h) in patients with inclusion

bodymyositis”,Brain,2009.

[15] Deportaalsitevoorzeldzameziektenenweesgeneesmiddelen,https://www.orpha.net,

May2019.

[16] Myositis.org,“Exerciseandphysicaltherapy”,TheMyositisAssociation,2019.

[17] E.A.Habers,M.vanBrussel,A.C.Langbroek–Amersfoort,A.vanRoyen-Kerkhof,and

T. Takken, “Design of the muscles in motion study: A randomized controlled trial  to evaluate the efficacy and feasibility of an individually tailored home-based exercise training program for children and adolescents with juvenile dermatomyositis,

13,108.”,BMCmusculoskeletaldisorders,2012.

[18] Y. Allenbach, O. Benveniste, V. Decostre, A. Canal, B. Eymard, S. Herson, C. Bloch

Queyrat, and J. Y. Hogrel, “Quadriceps strength is a sensitive marker of disease pro

gression in sporadic inclusion body myositis, 22(11), 980-6.”, Neuromuscular Disor

ders,2012.

[19] D. S. de Oliveira, R. G. Misse, F. R. Lima, and S. K. Shinjo, “Physical exercise among

patients with systemic autoimmune myopathies, 58(1), 5.”, International Journal of

AdvancesinRheumatology,2018.

[20] L. Dimitrijevic´, M. Aleksandrovic´, D. Madic´, T. Okicˇic´, D. Radovanovic´, and D. Daly,

“The effect of aquatic intervention on the gross motor function and aquatic skills in

childrenwithcerebralpalsy,32,167-174.”,JournalofHumanKinetic,2012.

[21] fysioDelft,Hydrotherapie,https://www.fysiodelft.nl/hydrotherapie.php.

[22] G.enwetenschap,Hogebloeddruk(hypertensie),

https://www.gezondheidenwetenschap.be/richtlijnen/hoge-bloeddruk-hypert…,

2014.

[23] D.physiotherapeut,Uitgebreidetoelichtingvanhetmeetinstrument,

https://www.meetinstrumentenzorg.nl/Home/SearchPost?meetinstrument=47,S….

2014.

[24] H. Alexanderson, L. Broman, A. Tollback, A. Josefson, I. E. Lundberg, and C. H. Sten

stro, “Functional index2: Validity and reliability of a disease specific measure of im

pairment in patients with polymyositis and dermatomyositis, 55(1),114-122.”, Artri

tisandRheumatology,2006.

[25] P. A. Bishop, E. Jones, and A. K. Woods, “Recovery from training: A brief review: Brief

review,22(3),1015-1024.”,JournalofStrengthandConditioningResearch,2008.

[26] 3athlon, Formule van karvonen, https://www.3athlon.be/2005/09/29/formule-van

karvonen/,Sep.2005.

[27] SchuitemakerandvanSchaik,24regel,https://www.fysio.net/index.php/client

patientinfo/180-patientinformatie-alfabetisch?highlight=WzI0LCJ1dX

IiLCJyZWdlbCIsIjI0IHV1ciIsIjI0IHV1ciByZWdlbCIsInV1ciByZWdlbCJd,2019.

[28] M.Sullivan,J.Karlsson,E.John,andJ.Ware,“Theswedishsf-36healthsurveyevalua

tionofdataquality,scalingassumptions,reliabilityandconstructvalidityacrossgen

eralpopulationsinsweden,41(10),1349-1358.”,SocialScienceandMedicine,1995.

[29] N. K. Aaronson, M. Muller, P. D. Cohen, M. L. Essink-Bot, M. Fekkes, R. Sanderman,

M. A. Sprangers, A. te Velde, and E. Verrips, “Translation, validation, and norming

of the dutch language version of the sf-36 health survey in community and chronic

diseasepopulations,51(11),1055-1068.”,JournalofClinicalEpidemiology,1998.

[30] Rand-Health-care,36-itemshortformsurvey(sf-36)scoringinstructions,https//

www.rand.org/health-care/surveys_tools/mos/36itemshortform/scoringtml.